Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway.
Ni C, Zhou L, Yang S, Ran M, Luo J, Cheng K, Huang F, Tang X, Xie X, Qin D, Mei Q, Wang L, Xiao J, Wu J.
Ni C, et al. Among authors: wu j.
J Pharm Anal. 2025 Jan;15(1):101054. doi: 10.1016/j.jpha.2024.101054. Epub 2024 Jul 23.
J Pharm Anal. 2025.
PMID: 39906691
Free PMC article.